A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes Post author:admin Post published:February 18, 2025 Post category:uncategorized Post comments:0 Comments New research shows sotagliflozin is the only drug in its class to demonstrate these results. You Might Also Like Botulism strikes during Rugby World Cup: How sardines benched eight fans in Bordeaux October 17, 2023 Blocking IL-11 protein extends lifespan and health in mice by 25%, study shows July 18, 2024 Healthcare professionals struggle to address childhood obesity due to training gap April 2, 2024 Leave a Reply Cancel replyYou must be logged in to post a comment.
Botulism strikes during Rugby World Cup: How sardines benched eight fans in Bordeaux October 17, 2023